The model empowers patients, shortens the treatment journey, and opens new opportunities for digital engagement
Your doctor recommended a GLP-1
Change in Color While a very slight yellow tint can be normal for some formulations, any significant change in colorsuch as turning dark yellow, brown, or pinkindicates that the medication has oxidized or reacted to light and heat
Others are delivered pre-sleep to take advantage of nocturnal GH peaks
Long-term safety and efficacy of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week open-label, multicenter, post-marketing clinical study
The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (The Diabetes & Aging Study)